Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Weight Loss 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Neoplasms 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1Malnutrition 1Insulin Resistance 1Hyperbilirubinemia 1Hyperandrogenism 1Hirsutism 1Heart Failure 1Gastrointestinal Stromal Tumors 1Fatigue 1Dyslipidemias 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Cachexia 1Basal Cell Nevus Syndrome 1

Interventions

Exercise 10Diet 6Caloric Restriction 5Metformin 4Octreotide 3Nutrition Assessment 3Cognitive Behavioral Therapy 3anamorelin 2Standard of Care 2Olanzapine 2Mirtazapine 2Melatonin 2Liraglutide 2Eicosapentaenoic Acid 2Diet, Carbohydrate-Restricted 2Diet Therapy 2sibutramine 1remune 1olanzapine-fluoxetine combination 1lime 1irinotecan sucrosofate 1bermekimab 1Weight Reduction Programs 1Urine Specimen Collection 1Tirzepatide 1TOPS 1Surveys and Questionnaires 1Sugars 1Sampling Studies 1Ritonavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Weight Loss × Carnitine × Clear all
NCT03151291 2018-10-16

Effects of WB-EMS and Specific Dietary Supplements on Cancer Patients

University of Erlangen-Nürnberg Medical School

Phase NA Unknown
200 enrolled

Motor Activity, Muscular Atrophy, Neoplasms, Weight Loss, Muscle Weakness

Data powered by HemOnc (CC BY 4.0) Colophon âš¡